FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386594927> ?p ?o ?g. }

• W4386594927 abstract "Introduction: Hyperkalemia, a common condition among hemodialysis (HD) patients, is associated with adverse health outcomes. Evidence of the safety and efficacy of a potassium-binder, sodium zirconium cyclosilicate (SZC), has been limited among Asian (HD) patients beyond phase 3 trials. This article demonstrates real-world evidence of SZC usage in an Asian cohort of HD patients. Methods: A retrospective clinical audit was conducted among 293 patients who received maintenance HD at community-based dialysis centers in Singapore. Patients received SZC for either management of hyperkalemia or hyperkalemia prevention during anticipated disruption to dialysis, such as during traveling. Among patients treated for hyperkalemia (N = 147), serum potassium (K+) prior to SZC initiation and at the endpoint was compared using a paired Student’s t-test. Changes in K+ from baseline to endpoint were compared across various categories within each demographic and health-related variables using either Student’s t-test or one-way ANOVA. Patients who experienced adverse events after SZC initiation or were deceased during the audit were reviewed to provide a descriptive account. Results: Among patients who received SZC for hyperkalemia treatment, SZC use was associated with a significant reduction of 0.812 mmol/L in serum potassium. Patients with ethnicities other than Chinese, Malay, or Indian had a nominal reduction in K+ of 0.7 mmol/L and this can be accounted for the small sample size of this sub-group. The three main ethnicities which represented more than 95% of the sample showed a significant reduction in K+ levels (all three p<0.001). This is consistent with other studies with SZC which showed efficacy across various ethnicities. Patients who received SZC for hyperkalemia treatment or prevention had a significant lowering of mortality rate. This mortality reduction may have inherent biases and confounders, due to the retrospective clinical audit study design. Conclusions: Overall, SZC was safe and effective among the audited patients. The efficacy in the real-world setting was similar to previous trials. The novel use of SZC to manage serum potassium when HD sessions are missed, such as during traveling, warrants further investigation due to potentially significant life-saving implications." @default.
• W4386594927 created "2023-09-12" @default.
• W4386594927 creator A5027394471 @default.
• W4386594927 creator A5046123355 @default.
• W4386594927 creator A5062107602 @default.
• W4386594927 date "2023-09-11" @default.
• W4386594927 modified "2023-10-15" @default.
• W4386594927 title "A Real-World Experience of Hyperkalemia Management Using Sodium Zirconium Cyclosilicate in Chronic Hemodialysis: A Multicenter Clinical Audit" @default.
• W4386594927 cites W2041162893 @default.
• W4386594927 cites W2192954951 @default.
• W4386594927 cites W2518204936 @default.
• W4386594927 cites W2609122307 @default.
• W4386594927 cites W2921441879 @default.
• W4386594927 cites W2946005791 @default.
• W4386594927 cites W2949981799 @default.
• W4386594927 cites W2950769791 @default.
• W4386594927 cites W2979523141 @default.
• W4386594927 cites W3000260122 @default.
• W4386594927 cites W3007902891 @default.
• W4386594927 cites W3108883993 @default.
• W4386594927 cites W3111149336 @default.
• W4386594927 cites W4228998000 @default.
• W4386594927 cites W4385898935 @default.
• W4386594927 doi "https://doi.org/10.7759/cureus.45058" @default.
• W4386594927 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37829953" @default.
• W4386594927 hasPublicationYear "2023" @default.
• W4386594927 type Work @default.
• W4386594927 citedByCount "0" @default.
• W4386594927 crossrefType "journal-article" @default.
• W4386594927 hasAuthorship W4386594927A5027394471 @default.
• W4386594927 hasAuthorship W4386594927A5046123355 @default.
• W4386594927 hasAuthorship W4386594927A5062107602 @default.
• W4386594927 hasBestOaLocation W43865949271 @default.
• W4386594927 hasConcept C126322002 @default.
• W4386594927 hasConcept C197934379 @default.
• W4386594927 hasConcept C203092338 @default.
• W4386594927 hasConcept C2778063415 @default.
• W4386594927 hasConcept C2779978075 @default.
• W4386594927 hasConcept C2780243291 @default.
• W4386594927 hasConcept C535046627 @default.
• W4386594927 hasConcept C71924100 @default.
• W4386594927 hasConceptScore W4386594927C126322002 @default.
• W4386594927 hasConceptScore W4386594927C197934379 @default.
• W4386594927 hasConceptScore W4386594927C203092338 @default.
• W4386594927 hasConceptScore W4386594927C2778063415 @default.
• W4386594927 hasConceptScore W4386594927C2779978075 @default.
• W4386594927 hasConceptScore W4386594927C2780243291 @default.
• W4386594927 hasConceptScore W4386594927C535046627 @default.
• W4386594927 hasConceptScore W4386594927C71924100 @default.
• W4386594927 hasLocation W43865949271 @default.
• W4386594927 hasLocation W43865949272 @default.
• W4386594927 hasOpenAccess W4386594927 @default.
• W4386594927 hasPrimaryLocation W43865949271 @default.
• W4386594927 hasRelatedWork W1577251610 @default.
• W4386594927 hasRelatedWork W1990676725 @default.
• W4386594927 hasRelatedWork W2006586291 @default.
• W4386594927 hasRelatedWork W2353267380 @default.
• W4386594927 hasRelatedWork W2369017040 @default.
• W4386594927 hasRelatedWork W2406506005 @default.
• W4386594927 hasRelatedWork W3214249464 @default.
• W4386594927 hasRelatedWork W4292006139 @default.
• W4386594927 hasRelatedWork W4322742330 @default.
• W4386594927 hasRelatedWork W4376471865 @default.
• W4386594927 isParatext "false" @default.
• W4386594927 isRetracted "false" @default.
• W4386594927 workType "article" @default.